Sodium-glucose co-transporters are responsible for 97% of glucose reabsorption6 and their inhibition lowers blood glucose by increasing renal glucose excretion.4 , 5 Using SGLT-2 inhibitors increases the risk of DKA6 , 7 by decreasing daily carbohydrate availability by 20%45%,9 lowering endogenous insulin production and stimulating lipolysis that leads to ketogenesis.6 Patients who also receive insulin may decrease insulin doses in response to lower blood glucose patterns, leading to insulin deficiency
Others claim it supports gut health, recovery, or even neurological repair
This large bottle lasts for 3 months - For best results keep applying when symptoms fade
Effects of retatrutide on body composition in people with type 2 diabetes
The SURMOUNT-1 trial demonstrated significant weight loss, with patients losing approximately 15-21% of their body weight at the 15 mg dose over 72 weeks, depending on the statistical method used
L-carnitine has also been linked to improvements in patients with severe heart disorders, such as coronary heart disease and chronic heart failure (x) (xx)